(Total Views: 421)
Posted On: 09/29/2025 9:42:02 PM
Post# of 157591
Quote:
I'm doubtful the rollover protocol has been rejected. Wouldn't make sense.
Being turned down was a reference to PD-L1 inhibitors being added to the current trial. Follow-up study and rollover study would be the same thing.

